Qube Research & Technologies (QRT)
DMK

Qube Research & Technologies (QRT)’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$69 – 4871
2023
Q3 		$69 Buy
+100
New +$128 ﹤0.01% 3791
2021
Q2 		– Sell
-463
Closed -$30K – 2922
2021
Q1 		$30K Sell
463
-1,973
-81% -$154K ﹤0.01% 1803
2020
Q4 		$83K Sell
2,436
-4,979
-67% -$221K ﹤0.01% 1664
2020
Q3 		$407K Buy
7,415
+6,197
+509% +$367K 0.01% 1115
2020
Q2 		$46K Buy
+1,218
New +$41.7K ﹤0.01% 1611

Other funds holding DMK

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DMK Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2023, closing a stake of 100 shares — an estimated $69 sold.

Qube Research & Technologies (QRT) first reported a position in DMK in Q2 2020 and held it in 5 quarters. The position peaked at $407K in Q3 2020. 29 funds tracked by Wall St. Rank hold DMK as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 100 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2023, an estimated $69.
  • Qube Research & Technologies (QRT) first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s DMK Pharmaceuticals Corporation Common Stock position peaked at $407K in Q3 2020.
  • 29 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.